Metropolitan Life Insurance Company (MetLife)’s DocGo DCGO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-2,646
Closed -$10.7K 572
2024
Q1
$10.7K Sell
2,646
-2,046
-44% -$7.72K ﹤0.01% 2115
2023
Q4
$26.2K Hold
4,692
﹤0.01% 1791
2023
Q3
$25K Hold
4,692
﹤0.01% 1783
2023
Q2
$44K Hold
4,692
﹤0.01% 1498
2023
Q1
$40.6K Sell
4,692
-447
-9% -$3.94K ﹤0.01% 1513
2022
Q4
$36.3K Hold
5,139
﹤0.01% 1676
2022
Q3
$51K Hold
5,139
﹤0.01% 1451
2022
Q2
$36.7K Buy
+5,139
New +$37.5K ﹤0.01% 1691

Other funds holding DCGO

Metropolitan Life Insurance Company (MetLife)'s DCGO Position: Q2 2024 in Review

Metropolitan Life Insurance Company (MetLife) sold out of DocGo (DCGO) in Q2 2024, closing a stake of 2,646 shares — an estimated $10.7K sold.

Metropolitan Life Insurance Company (MetLife) first reported a position in DCGO in Q2 2022 and held it in 8 quarters. The position peaked at $51K in Q3 2022. 123 funds tracked by Wall St. Rank hold DCGO as of Q2 2024.

  • Metropolitan Life Insurance Company (MetLife) reported no remaining DocGo position as of Q2 2024 after selling out during the quarter.
  • Metropolitan Life Insurance Company (MetLife) sold 2,646 DocGo shares in Q2 2024, an estimated $10.7K.
  • Metropolitan Life Insurance Company (MetLife) first reported a position in DocGo in Q2 2022 and held it in 8 quarters.
  • Metropolitan Life Insurance Company (MetLife)'s DocGo position peaked at $51K in Q3 2022.
  • 123 funds tracked by Wall St. Rank held DocGo as of Q2 2024.

Based on Metropolitan Life Insurance Company (MetLife)'s 13F filing for Q2 2024, filed 13 Aug 2024.